1227601-71-9

Usage

Uses

Used in Pharmaceutical Synthesis:
(3-bromo-6-chloropyridin-2-yl)methanol is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs and biologically active compounds.
Used in Agrochemical Development:
In the agrochemical industry, (3-bromo-6-chloropyridin-2-yl)methanol is utilized as a building block for the creation of pesticides and other agrochemicals, leveraging its chemical properties to enhance crop protection and yield.
Used in Materials Science:
(3-bromo-6-chloropyridin-2-yl)methanol is employed as a component in the development of functional materials, where its unique structure and properties can be harnessed to create materials with specific characteristics for various applications.
Used in Antibacterial and Antifungal Applications:
Due to its inherent antibacterial and antifungal properties, (3-bromo-6-chloropyridin-2-yl)methanol is used in medical and agricultural settings to combat infections and control the growth of harmful microorganisms, thereby contributing to public health and food safety.

Upstream product

• 1214328-96-7 methyl 3-bromo-6-chloro-pyridine-2-carboxylate 
• 929000-66-8 3-bromo-6-chloropyridine-2-carboxylic acid 

Relevant academic research and scientific papers

HPK1 ANTAGONISTS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.

Novel heterocyclic derivative capable of being used as SHP2 inhibitor

The invention relates to a novel heterocyclic derivative capable of being used as an SHP2 inhibitor, specifically relates to a compound shown by a formula I or pharmaceutically acceptable salts thereof, further relates to a use of the compound shown by the formula I or the pharmaceutically acceptable salts thereof and a pharmaceutical composition thereof in drug preparation, and particularly relates to a use in preparation of drugs for treatment, inhibition or prevention of diseases or discomforts mediated by SHP2 activity.

NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.

COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE

The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of IDO, and for the treatment of IDO-related disorders.